These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26280924)

  • 1. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
    J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preformulation study of fiber formation and formulation of drug-loaded microfiber based orodispersible tablets for in vitro dissolution enhancement.
    Szabó P; Kállai-Szabó B; Sebe I; Zelkó R
    Int J Pharm; 2014 Dec; 477(1-2):643-9. PubMed ID: 25448565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on formulation development of mouth dissolving tablets of Carvedilol.
    Pokharkar V; Dhar S; Mandpe L
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):21-8. PubMed ID: 19957540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of nanofibrous sheets for enhanced oral dissolution of nebivolol hydrochloride.
    Sipos E; Szabó ZI; Rédai E; Szabó P; Sebe I; Zelkó R
    J Pharm Biomed Anal; 2016 Sep; 129():224-228. PubMed ID: 27433987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH; Bandari S; Jukanti R; Veerareddy PR
    Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate.
    Srikanth Meka V; Wee Liang VA; Dharmalingham SR; Sheshala R; Gorajana A
    Acta Pharm; 2014 Dec; 64(4):485-94. PubMed ID: 25531788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits.
    Aljimaee YH; El-Helw AR; Ahmed OA; El-Say KM
    Drug Des Devel Ther; 2015; 9():1379-92. PubMed ID: 25834396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and correlation of the physicochemical properties of carvedilol.
    Alves JM; Prado LD; Rocha HV
    Pharm Dev Technol; 2016 Nov; 21(7):856-866. PubMed ID: 26336079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improvement in physicochemical properties of carvedilol through spherically agglomerated solid dispersions with PVP K30.
    Tapas A; Kawtikwar P; Sakarkar D
    Acta Pol Pharm; 2012; 69(2):299-308. PubMed ID: 22568045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic development of pH-independent controlled release tablets of carvedilol using central composite design and artificial neural networks.
    Aktas E; Eroglu H; Kockan U; Oner L
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1207-16. PubMed ID: 22804226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
    Shah PP; Mashru RC
    AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica.
    Planinšek O; Kovačič B; Vrečer F
    Int J Pharm; 2011 Mar; 406(1-2):41-8. PubMed ID: 21219991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.